{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:27:50Z","timestamp":1783445270075,"version":"3.54.6"},"reference-count":22,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":3450,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective: Finding agranulocytosis (AG) at an early stage is important to improve outcome, but periodic granulocyte count monitoring is not generally recommended for patients with Graves' disease, because AG develops suddenly. Method: At the Kuma Hospital, Graves' patients under antithyroid drug (ATD) treatment in an outpatient clinic have a granulocyte count examination during each visit, and if it is &amp;lt;1,000\/\u03bcl, a warning is immediately sent to the patient's physician. We evaluated the usefulness of this system. Results: We investigated 25 AG and 33 granulocytopenia (GP) cases over a recent 5-year period, excluding patients who developed AG or GP at another hospital and were referred to us for treatment. Among the 25 AG patients, 16 patients (64%; 9 asymptomatic and 7 very mild symptomatic cases) were discovered by the periodic granulocyte count examination at an outpatient clinic. The remaining 9 patients visited the Kuma Hospital or other hospitals because of infection symptoms. Most of the AG patients were given granulocyte colony-stimulating factor injections immediately and were admitted if a prompt increase in granulocytes could not be obtained. The final treatments for Graves' disease were &amp;lt;sup&amp;gt;131&amp;lt;\/sup&amp;gt;I-radioisotope therapy (19 patients), thyroidectomy (2 patients), inorganic iodine (1 patient), or another ATD (1 patient). Among the 33 GP patients, 31 (94%), including 20 asymptomatic cases, were discovered during periodic granulocyte count monitoring. Most of them stopped ATD, and other treatments for Graves' disease were selected. Conclusion: Periodic monitoring of granulocyte counts is useful for identifying AG and GP patients with no or minimum infection symptoms.<\/jats:p>","DOI":"10.1159\/000448586","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T17:01:56Z","timestamp":1473094916000},"page":"253-260","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":12,"title":["Periodic Granulocyte Count Measuring Is Useful for Detecting Asymptomatic Agranulocytosis in Antithyroid Drug-Treated Patients with Graves' Disease"],"prefix":"10.1530","volume":"5","author":[{"given":"Hirotoshi","family":"Nakamura","sequence":"first","affiliation":[{"name":"1Kuma Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Ide","sequence":"additional","affiliation":[{"name":"1Kuma Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kudo","sequence":"additional","affiliation":[{"name":"1Kuma Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijun","family":"Nishihara","sequence":"additional","affiliation":[{"name":"1Kuma Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ito","sequence":"additional","affiliation":[{"name":"1Kuma Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"1Kuma Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"2026070712482655700_ref1","doi-asserted-by":"crossref","unstructured":"Andres E, Zimmer J, Mecili M, Weitten T, Alt M, Maloisel F: Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol 2011;4:143-151.10.1586\/ehm.11.1221495924","DOI":"10.1586\/ehm.11.12"},{"key":"2026070712482655700_ref2","doi-asserted-by":"crossref","unstructured":"Nakamura H, Miyauchi A, Miyawaki N, Imagawa J: Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab 2013;98:4776-4783.10.1210\/jc.2013-256924057289","DOI":"10.1210\/jc.2013-2569"},{"key":"2026070712482655700_ref3","doi-asserted-by":"crossref","unstructured":"Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN: Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593-646.10.1089\/thy.2010.041721510801","DOI":"10.1089\/thy.2010.0417"},{"key":"2026070712482655700_ref4","doi-asserted-by":"crossref","unstructured":"Brent GA: Clinical practice. Graves' disease. N Engl J Med 2008;358:2594-2605.10.1056\/NEJMcp080188018550875","DOI":"10.1056\/NEJMcp0801880"},{"key":"2026070712482655700_ref5","doi-asserted-by":"crossref","unstructured":"Franklyn JA, Boelaert K: Thyrotoxicosis. Lancet 2012;379:1155-1166.10.1016\/S0140-6736(11)60782-422394559","DOI":"10.1016\/S0140-6736(11)60782-4"},{"key":"2026070712482655700_ref6","doi-asserted-by":"crossref","unstructured":"Tajiri J, Noguchi S, Murakami T, Murakami N: Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150:621-624.10.1001\/archinte.1990.003901501070202310281","DOI":"10.1001\/archinte.1990.00390150107020"},{"key":"2026070712482655700_ref7","doi-asserted-by":"crossref","unstructured":"Elaboration: Drug-induced agranulocytosis - monitoring antithyroid treatment. Drug Ther Bull 1997;35:88.10.1136\/dtb.1997.3511889464005","DOI":"10.1136\/dtb.1997.351188"},{"key":"2026070712482655700_ref8","doi-asserted-by":"crossref","unstructured":"Sobel R, Glick S: Monitoring antithyroid therapy. Arch Intern Med 1993;153:2797.10.1001\/archinte.1993.004102401090157504914","DOI":"10.1001\/archinte.1993.00410240109015"},{"key":"2026070712482655700_ref9","unstructured":"Bhatt V, Saleem A: Review: drug-induced neutropenia - pathophysiology, clinical features, and management. Ann Clin Lab Sci 2004;34:131-137.15228223"},{"key":"2026070712482655700_ref10","unstructured":"Bilezikian SB, Laleli Y, Tsan MF, Hodkinson BA, Ice S, McIntyre PA: Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs. Johns Hopkins Med J 1976;138:124-129.58084"},{"key":"2026070712482655700_ref11","doi-asserted-by":"crossref","unstructured":"Guffy MM, Goeken NE, Burns CP: Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. Arch Intern Med 1984;144:1687-1688.6205633","DOI":"10.1001\/archinte.144.8.1687"},{"key":"2026070712482655700_ref12","doi-asserted-by":"crossref","unstructured":"Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH: Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 1986;64:363-373.10.1111\/j.1365-2141.1986.tb04130.x3778829","DOI":"10.1111\/j.1365-2141.1986.tb04130.x"},{"key":"2026070712482655700_ref13","doi-asserted-by":"crossref","unstructured":"Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A: Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 2009;19:559-563.10.1089\/thy.2008.036419445623","DOI":"10.1089\/thy.2008.0364"},{"key":"2026070712482655700_ref14","doi-asserted-by":"crossref","unstructured":"Watanabe N, Narimatsu H, Noh JY, Yamaguchi T, Kobayashi K, Kami M, Kunii Y, Mukasa K, Ito K: Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab 2012;97:E49-E53.10.1210\/jc.2011-222122049174","DOI":"10.1210\/jc.2011-2221"},{"key":"2026070712482655700_ref15","doi-asserted-by":"crossref","unstructured":"Yang J, Zhu YJ, Zhong JJ, Zhang J, Weng WW, Liu ZF, Xu Q, Dong MJ: Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: a retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years. Thyroid 2016;26:627-633.10.1089\/thy.2015.043926867063","DOI":"10.1089\/thy.2015.0439"},{"key":"2026070712482655700_ref16","doi-asserted-by":"crossref","unstructured":"Robinson J, Richardson M, Hickey J, James A, Pearce SH, Ball SG, Quinton R, Morris M, Miller M, Perros P: Patient knowledge of antithyroid drug-induced agranulocytosis. Eur Thyroid J 2014;3:245-251.10.1159\/00036799025759801","DOI":"10.1159\/000367990"},{"key":"2026070712482655700_ref17","doi-asserted-by":"crossref","unstructured":"Tajiri J, Noguchi S: Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 2004;14:459-462.10.1089\/10507250432315078715242574","DOI":"10.1089\/105072504323150787"},{"key":"2026070712482655700_ref18","doi-asserted-by":"crossref","unstructured":"Asawa T, Arai M, Takeda T, Aizawa T, Yamada T, Onishi Y: Antithyroid drug-induced agranulocytosis: is routine white blood cell count effective for the detection? Arch Intern Med 1992;152:204, 207.10.1001\/archinte.1992.004001301940301370251","DOI":"10.1001\/archinte.1992.00400130194030"},{"key":"2026070712482655700_ref19","doi-asserted-by":"crossref","unstructured":"Chen PL, Shih SR, Wang PW, Lin YC, Chu CC, Lin JH, Chen SC, Chang CC, Huang TS, Tsai KS, Tseng FY, Wang CY, Lu JY, Chiu WY, Chang CC, Chen YH, Chen YT, Fann CS, Yang WS, Chang TC: Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun 2015;6:7633.10.1038\/ncomms863326151496","DOI":"10.1038\/ncomms8633"},{"key":"2026070712482655700_ref20","doi-asserted-by":"crossref","unstructured":"Cheung CL, Sing CW, Tang C, Cheng V, Pirmohamed M, Choi CH, Hung CS, Lau EF, Lee KF, Mak MH, Leung J, Wong TW, Ho A, Chan KW, Hung V, Tam V, Siu SC, Pang HK, Wat WM, Lee HY, Chung CT, Hue RM, Sham PC, Cheung B, Wong I, Tan K, Kung A: HLA-B*38:02:01 predicts carbimazole\/methimazole-induced agranulocytosis. Clin Pharmacol Ther 2016;99:555-561.10.1002\/cpt.30926599303","DOI":"10.1002\/cpt.309"},{"key":"2026070712482655700_ref21","doi-asserted-by":"crossref","unstructured":"Hallberg P, Eriksson N, Ibanez L, Bondon-Guitton E, Kreutz R, Carvajal A, Lucena MI, Ponce ES, Molokhia M, Martin J, Axelsson T, Yue QY, Magnusson PK, Wadelius M, EuDAC Collaborators: Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol 2016;4:507-516.10.1016\/S2213-8587(16)00113-327157822","DOI":"10.1016\/S2213-8587(16)00113-3"},{"key":"2026070712482655700_ref22","doi-asserted-by":"crossref","unstructured":"Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, Kamatani Y, Takahashi A, Kubo M: Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese. Nat Genet 2015;47:798-802.10.1038\/ng.331026029868","DOI":"10.1038\/ng.3310"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/448586","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/5\/4\/253\/29758\/etj448586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/5\/4\/253\/29758\/etj448586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:12:36Z","timestamp":1783444356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/5\/4\/253\/4027\/Periodic-Granulocyte-Count-Measuring-Is-Useful-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000448586","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}